Eric J. Ende

Insider Reports History

Entity
Individual
Location
C/O Matinas Biopharma Holdings, Inc., 1545 Route 206 South, Suite 302, Bedminster, NJ
Signature
/s/ Jerad G. Seurer, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric J. Ende:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Matinas BioPharma Holdings, Inc. Director Stock option (right to buy) 437K Nov 1, 2023 Direct
AVADEL PHARMACEUTICALS PLC Director Ordinary Shares 179K Jul 30, 2024 Direct
NeuBase Therapeutics, Inc. Director Stock option (right to buy) 37.6K Sep 9, 2022 Direct
AVADEL PHARMACEUTICALS PLC Director Stock Option (Right to Buy) 11K Jul 30, 2024 Direct

Insider Reports Filed by Eric J. Ende

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVDL AVADEL PHARMACEUTICALS PLC Jul 30, 2024 2 $0 4 Aug 1, 2024 Director
MTNB Matinas BioPharma Holdings, Inc. Nov 1, 2023 1 $0 4 Nov 3, 2023 Director
AVDL AVADEL PHARMACEUTICALS PLC Aug 1, 2023 1 $0 4 Aug 3, 2023 Director
AVDL AVADEL PHARMACEUTICALS PLC May 18, 2023 1 $181K 4 May 19, 2023 Director
AVDL AVADEL PHARMACEUTICALS PLC Nov 22, 2022 1 $156K 4 Nov 23, 2022 Director
MTNB Matinas BioPharma Holdings, Inc. Nov 14, 2022 1 $0 4 Nov 16, 2022 Director
NBSE NeuBase Therapeutics, Inc. Sep 9, 2022 1 $0 4 Sep 12, 2022 Director
AVDL AVADEL PHARMACEUTICALS PLC Aug 3, 2022 1 $0 4 Aug 5, 2022 Director
AVDL AVADEL PHARMACEUTICALS PLC May 31, 2022 2 $77.9K 4 Jun 1, 2022 Director
AVDL AVADEL PHARMACEUTICALS PLC May 27, 2022 1 $36.7K 4 May 31, 2022 Director
NBSE NeuBase Therapeutics, Inc. Jan 1, 2022 1 $0 4 Jan 5, 2022 Director
NBSE NeuBase Therapeutics, Inc. Jan 1, 2022 0 $0 3 Jan 5, 2022 Director
MTNB Matinas BioPharma Holdings, Inc. Nov 1, 2021 1 $0 4 Nov 2, 2021 Director
AVDL AVADEL PHARMACEUTICALS PLC Aug 3, 2021 1 $0 4 Aug 5, 2021 Director
MTNB Matinas BioPharma Holdings, Inc. Jun 19, 2021 3 $0 4 Jun 24, 2021 Director